HMS Appoints Two Healthcare Veterans to New Leadership Roles
January 08 2018 - 8:30AM
HMS (NASDAQ:HMSY) today announced that Emmet O’Gara and Michael
Cole, two veteran healthcare executives, have joined HMS in newly
created positions to help accelerate the company’s growth
initiatives. This includes driving growth through its consumer
engagement business, care management platform and analytics
offerings.
Emmet O’Gara, formerly senior vice president
and chief revenue officer for Cota—a healthcare data and analytics
company—joins HMS as executive vice president, Total Population
Management (TPM). O’Gara will oversee all aspects of the company’s
TPM business development, product innovation and delivery
capabilities. His responsibilities include leadership of Eliza, a
health engagement business HMS acquired in April 2017. Based in
Eliza’s headquarters in Danvers, Massachusetts, O’Gara reports to
HMS Chairman and CEO Bill Lucia.
O’Gara brings more than 25 years of experience in the healthcare
payer, provider and employer markets. Prior to Cota, he served as
senior vice president and general manager of Payer and Provider
Solutions at MedeAnalytics, a leading healthcare analytics company.
During his eight-year tenure, O’Gara drove new sales, expanded
existing accounts and accelerated revenue growth. He previously
held key leadership roles at Blue Cross Blue Shield of
Massachusetts, Accenture and Cigna Healthcare.
Michael Cole, formerly national vice president
for health plans at Quest Diagnostics, joins HMS as senior vice
president, Commercial Markets. He is responsible for driving and
executing growth strategies for HMS’ commercial business, including
cross-sales of Eliza consumer engagement solutions. He also will
oversee customer engagement and account management for the
company’s 325 health plan clients. Based in Chicago, Illinois, Cole
reports to Doug Williams, HMS’ president of Markets and
Product.
With 27 years in the healthcare industry, Cole has a proven
track record of generating growth and leading large-scale
operations. Prior to Quest Diagnostics, he spent 10 years at
UnitedHealthcare (UHC), where he last served as national vice
president, Employer and Individual Markets—a major business segment
with 7.6 million covered members. Cole also served as chief
operating officer for UnitedHealthcare of Illinois. Previously, he
spent 12 years at Cigna Healthcare of Illinois, where he was a new
business manager leading sales strategy and execution for multiple
employee healthcare services.
“I am delighted to welcome Emmet and Mike to the HMS team,” said
Bill Lucia, HMS’ chairman and CEO. “Both are accomplished and
well-connected healthcare leaders who know how to navigate the
complexities and ever-changing landscape of our healthcare system.
They will be instrumental in executing our growth plans, while
helping our customers contain costs and effectively engage their
members in their own health.”
About HMSHMS is a leading provider of cost
containment solutions to the U.S. healthcare market. Our solutions
improve financial and health outcomes for organizations at risk.
Using innovative technology and powerful data analytics, we help
clients reduce costs, increase quality and achieve regulatory
compliance. As a result of our services, clients save billions of
dollars annually. Visit us at www.hms.com or follow us on Twitter
at @HMSHealthcare.
Contact:Elizabeth Bonet, HMS972 894
8405elizabeth.bonet@hms.com
HMS (NASDAQ:HMSY)
Historical Stock Chart
From Jun 2024 to Jul 2024
HMS (NASDAQ:HMSY)
Historical Stock Chart
From Jul 2023 to Jul 2024